Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.
Irmak KaracaElaine M TranSungWho ParkAlbert BromeoHassan KhojastehAnh Ngọc Tram TranNegin YavariAmir AkhavanrezayatCigdem YasarGunay Uludag KirimliNgoc Tuong Trong ThanMuhammad HassanChristopher OrHashem GhorabaDiana V DoQuan Dong NguyenPublished in: Journal of ophthalmic inflammation and infection (2024)
CP therapy can be considered a potentially effective and relatively safe therapeutic option for patients with severe ocular inflammatory diseases who failed other IMTs including biologics (TNFa and CD20 inhibitors).